UPSC solved previous year questions

UPSC Biotechnology PYQ with Answers

20 solved Biotechnology questions from previous UPSC papers, each with an answer and explanation.

Questions
20
Years covered
2016–2026
Exam years
11
With answers
20

Biotechnology questions by year

UPSC Biotechnology PYQ with Answers

1–3 of 3
  1. Q2 2025 Prelims GS

    With reference to monoclonal antibodies, often mentioned in news, consider the following statements: I. They are man-made proteins. II. They stimulate immunological function due to their ability to bind to specific antigens. III. They are used in treating viral infections like that of Nipah virus. Which of the statements given above are correct?

    1. I and II only
    2. II and III only
    3. I and III only
    4. I, II and IIIβœ“
    Answer explanation

    I, II and III Monoclonal antibodies are laboratory-engineered (man-made) proteins designed to bind specifically to target antigens, thereby triggering or supporting immune responses, and they have been used/explored as treatments for viral…

    BiotechnologyMonoclonal antibodiesScience and technology
    Read full explanation
  2. Q3 2024 Mains GS3

    What is the present world scenario of intellectual property rights with respect to life materials? Although, India is second in the world to file patents, still only a few have been commercialized. Explain the reasons behind this limited commercialization. (Answer in 150 words)

    Answer explanation

    Introduction Life-material patents sit at the intersection of innovation, public health, biodiversity and ethical limits on ownership of living resources.…

    BiotechnologyIntellectual propertyPatent commercialisation
    Read full explanation

17 more questions are premium

Free access covers 2025 and 2024 papers. Log in to practise free questions, or upgrade to unlock every year with answers and explanations.

Log in to continue

Padhlona is an independent preparation platform and is not affiliated with UPSC or the Government of India.